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Summary
The SV40 small t antigen (ST) interacts with the serine-threonine protein phosphatase 2A (PP2A). To investigate the role
of this interaction in transformation, we suppressed the expression of the PP2A B56 subunit in human embryonic kidney
(HEK) epithelial cells expressing SV40 large T antigen, hTERT, and H-RAS. Suppression of PP2A B56 expression inhibited
PP2A-specific phosphatase activity similar to that achieved by ST and conferred the ability to grow in an anchorage-
independent fashion and to form tumors. Overexpression of PP2A B563 in tumorigenic HEK cells expressing ST or human
lung cancer cell lines partially reversed the tumorigenicity of these cells. These observations identify specific PP2A com-
plexes involved in human cell transformation.
Introduction introduction of ST (Yu et al., 2001; Hahn et al., 2002). These
observations reconfirm earlier studies suggesting that ST plays
a critical role in human cell transformation (Bikel et al., 1987;The study of the interactions between DNA tumor virus-encoded
proteins and host cell proteins has uncovered a number of de Ronde et al., 1989).
Using mutant versions of ST, several groups have shownintracellular pathways that permit efficient viral replication.
Some of these same molecular interactions also program the that the ability of ST to transform human cells requires interac-
tions with PP2A, a family of abundantly expressed serine-threo-malignant state in susceptible cells and mimic alterations found
in human cancers. In particular, the study of the viral oncopro- nine phosphatases (Pallas et al., 1990; Mungre et al., 1994;
Rundell and Parakati, 2001; Yu et al., 2001; Hahn et al., 2002).teins encoded by the SV40 early region (SV40 ER) has revealed
critical host cell pathways whose perturbation plays an essential PP2A is a heterotrimer composed of catalytic C subunit, a struc-
tural A subunit, and one of several regulatory B-type subunits.role in the experimental transformation of mammalian cells. Re-
cent work has reinvestigated the roles of two SV40 ER oncopro- Several lines of evidence suggest that the interaction of PP2A
with ST results in the displacement of at least one PP2A Bteins, the large T antigen (LT) and the small t antigen (ST), in
human cell transformation (Ali and DeCaprio, 2001; Rundell and subunit and the inhibition of PP2A activity (Pallas et al., 1990;
Sontag et al., 1993; Mumby, 1995). However, it remains unclearParakati, 2001). Coexpression of these two oncoproteins to-
gether with the telomerase catalytic subunit, hTERT, and an whether the interaction of ST with PP2A displaces some or all
of the B subunits.oncogenic version of the H-RAS oncoprotein, suffices to trans-
form human cells (Yu et al., 2001; Hahn et al., 2002). LT inacti- Adding to this complexity, the PP2A A and C subunit each
exist as two isoforms, and the B subunits fall into four largelyvates two key tumor suppressor pathways by binding to the
retinoblastoma protein (pRB) and p53 (Ali and DeCaprio, 2001). unrelated families named B (also known as B55 and PR55), B
(also known as B56 and PR61), B″ (also known as PR72, PR130,Human cells expressing LT, hTERT, and H-RAS are immortal;
however, such cells fail to grow in an anchorage-independent PR59 or PR48) and B″ (putative; also known as PR93/SG2NA
or PR110/Striatin). Each of these B families is composed ofmanner or to form tumors in animals without the additional
S I G N I F I C A N C E
The introduction of the SV40 early region, the telomerase catalytic subunit (hTERT), and an oncogenic allele of H-RAS directly transforms
several different types of primary human cells. SV40 ST, which forms complexes with and inhibits PP2A, is one of the SV40 early region
oncoproteins that plays a critical role in human cell transformation. Here, we demonstrate that suppressing the expression of a
specific PP2A subunit, B56, is sufficient to convert immortal HEK cells into cells capable of forming tumors in immunodeficient mice.
Moreover, overexpression of PP2A B563 displaces ST and partially reverses ST-induced tumorigenicity. These findings suggest that
ST targets PP2A enzymatic complexes containing the B56 subunit, and that alterations in expression of this subunit contribute to
cancer development.
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several different members, all of which bind to the A subunit in
what is believed to be a mutually exclusive manner to form
distinct ABC holoenzyme complexes (Cohen, 1989; Scho¨nthal,
2001; Li and Virshup, 2002).
Several isoforms have been identified within each of the
PP2A B subunit families. For example, the PP2A B56 gene
belongs to the PP2A B56 (also called PR61 or B subunit) family
that consists of  (PPP2R5A),  (PPP2R5B),  (PPP2R5C), 
(PPP2R5D), and  (PPP2R5E) isoforms (Csortos et al., 1996;
McCright et al., 1996). The PP2A B56 gene locus resides at
14q32.2 and encodes three differentially spliced variants, PP2A
B561, B562, and B563 (Muneer et al., 2002). Each of these
alternative splice forms shares the first 12 exons of the PP2A
B56 gene. The longest form, PP2A B563, consists of 14 ex-
ons, whereas exon 13 is absent in the medium length form,
PP2A B562. The shortest form, PP2A B561, ends in an extra
alternatively spliced exon 12a. The PP2A B56 subunit isoforms Figure 1. Inhibition of PP2A by okadaic acid (OA) leads to cell transformation
are abundantly expressed in human heart and skeletal muscle A: OA stimulates HEK TERV cell proliferation. 104 cells were treated with
(McCright and Virshup, 1995) and localize to the nucleus when OA and counted at the time points shown. OA was used at the following
concentrations: 0 (), 74 pM (), 220 pM (), and 670 pM (). HEK TERSTexpressed in green monkey kidney cells (McCright et al., 1996)
cells are represented by (). Data are expressed as the mean  standardand murine NIH 3T3 cells (Tehrani et al., 1996). Members of the
deviation (SD) for 3 experiments.PP2A B56 family bind the adenomatous polyposis coli (APC)
B: Anchorage-independent growth of OA-treated TERV cells. HEK TERV or
tumor suppressor (Seeling et al., 1999; Polakis, 2000) and cyclin HEK TERST cells were seeded into 0.4% Noble agar and treated with OA as
G (Okamoto et al., 1996; Bennin et al., 2002; Okamoto et al., indicated. The number of colonies that formed after 28 days is reported as
the mean SD for 3 experiments. Gray bars represent HEK TERV cells treated2002). However, despite these important biochemical and cell
with OA. The black bar represents HEK TERST cells. Treatment of HEK TERSTbiological characterizations, the role(s) of the PP2A B56 iso-
with 670 pM OA failed to alter growth of these cells in soft agar.
forms in human cell transformation remain incompletely under-
stood.
In order to understand the signaling pathways perturbed by
the interaction of ST with PP2A, we studied the effects of altering with 6 nM OA induced 50% cell death at 24 hr (see Experimental
the interaction of particular B subunits with the PP2A A and C Procedures). Thus, in these studies, we used OA at picomolar
subunits. Here, we demonstrate that suppression of the PP2A concentrations to study the effects of OA on PP2A-specific
B56 subunit mimics the introduction of ST and permits cell phosphatase activity, cell proliferation, and anchorage-indepen-
transformation. Moreover, expression of wild-type PP2A B563 dent growth.
partially reverses cell transformation in experimental models
Subconfluent cultures of HEK TERV cells were treated with
dependent on ST as well as in human lung cancer cell lines.
OA at concentrations of 74 pM, 220 pM, and 670 pM, and PP2A
Taken together, these observations suggest that alterations in
activity was measured using the consensus peptide RRA(pT)VA.
PP2A play an important role in malignant transformation.
Under these conditions, we detected a dose-dependent reduc-
tion in PP2A activity immediately after treatment that persistedResults
for at least 24 hr (data not shown). Correlating with this inhibition
of PP2A phosphatase activity, we noted that treatment withEffects of ST on PP2A phosphatase activity
these same concentrations of OA led to an increase in the rateIn prior studies, we identified a set of genetic elements that,
of cell proliferation (Figure 1A). Indeed, HEK TERV cells treatedwhen introduced into primary human cells, converted these cells
with OA at 670 pM proliferated at nearly the same rate as cellsto tumorigenicity (Hahn et al., 1999). Human embryonic kidney
expressing ST (TERST). Moreover, treatment of HEK TERV cells(HEK) cells expressing LT, hTERT, oncogenic H-RAS, and ST
with OA conferred the ability to grow in an anchorage-indepen-(HEK TERST) form tumors in immunodeficient mice, whereas
dent fashion (Figure 1B). Taken together, these observationscells expressing only LT, hTERT, and oncogenic H-RAS (HEK
indicate that the pharmacologic inhibition of PP2A leads to simi-TERV) are immortal but not tumorigenic (Hahn et al., 2002).
lar functional outcomes induced by the expression of ST.Since previous studies had shown that ST interacts with and
inhibits PP2A (Pallas et al., 1990; Sontag et al., 1993; Mumby,
Downregulation of PP2A B56 in HEK cells1995), we determined whether pharmacologic inhibition of PP2A
Previous studies suggested that ST displaces the PP2A B55was sufficient to cooperate with LT, hTERT, and H-RAS to trans-
subunit (Pallas et al., 1990; Sontag et al., 1993; Mumby, 1995).form human cells by treating HEK TERV cells with the polyether
To identify whether ST interacts with specific PP2A heterotrim-toxin okadaic acid (OA), a highly selective inhibitor of protein
ers in addition to those containing PP2A B55, we developedphosphatase type 1 (PP1) and 2A (PP2A). In mammalian cells,
antisense RNA reagents to members of the PP2A B55 and B56PP1 and PP2A account for more than 90% of total protein
families and introduced them into HEK TER cells to create HEKserine/threonine phosphatase activity (Fernandez et al., 2002).
TERAS55 (B55 antisense construct) and HEK TERAS563OA inhibits PP2A (IC50 0.2–1 nM) much more potently than PP1
(B563 antisense construct) cells. Using primers specific for(IC50 20 nM) (Bialojan and Takai, 1988; Cohen, 1989; Fernandez
et al., 2002). We determined that treatment of HEK TERV cells the antisense constructs, we confirmed that these antisense
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Figure 2. Suppression of PP2A B56 by PP2A
B563 antisense RNA
A: Total RNA was isolated from HEK TERV (control
vector), HEK TERST (ST-expressing), HEK TER-
ASB563 (PP2A B563 antisense-expressing), and
HEK TERAS55 (PP2A B55 antisense-expressing),
and RT-PCR was performed using primers specific
for the PP2A B56 and B55 antisense-RNA con-
structs. RT-PCR for -actin confirmed the pres-
ence of equal amounts of RNA in each sample.
B: Immunoblotting of whole cell lysates (100 g)
derived from the cells described in A performed
with antibodies specific for PP2A A, B55, B56,
B56, B562 and B563 (indicated as B56), B56,
and C. Immunoblotting for -actin confirmed
that equal amounts of protein were loaded for
each sample.
C: HEK TERV, TERST, TERASB563, and TERAS55
cells were grown in medium supplemented with
standard amino acid concentrations (normal),
low concentrations of glutamine (0.375 mM), or
low concentrations of leucine (80 M) as indi-
cated. Cells were counted at the indicated time
points for HEK TERV (), TERST (), TERAS563 (),
and TERAS55 cells (). Data are expressed as
the mean  SD for 3 experiments.
D: Serine/threonine phosphatase activity for HEK
TERV, TERST, TERAS563, and TERAS55 cells. Pro-
tein phosphatase activity was performed on im-
mune complexes isolated by an antibody (6F9)
specific for PP2A A. Results are reported as pmol
free PO4 generated/g protein/min and are
expressed as the mean  SD for 3 experiments. Significant differences (indicated as *) were found in TERST cells (p 	 0.001) and TERASB563 cells (p 	
0.001) comparing to TERV cells using student t test.
E: For anchorage-independent growth, 105 cells were seeded into 0.4% Noble agar and colonies counted after 4 weeks. The mean  SD for 3 experiments
is shown. For tumorigenicity assays, 2 
 106 cells were injected subcutaneously into immunodeficient mice and are reported as number of tumors formed/
number of injection sites.
constructs were expressed (Figure 2A). The PP2A B55 anti- tion. We had previously shown that expression of SV40 ST
stimulates cell proliferation, confers resistance to nutrient depri-sense construct suppressed B55 protein expression by 40%,
while the PP2A B563 antisense construct nearly completely vation, and permits anchorage-independent growth and tumor
formation in immunodeficient mice (Hahn et al., 2002). Usingsuppressed B56 protein expression (Figure 2B). Since the anti-
body specific for B56 used in these experiments recognizes the HEK TERAS563 cells, we found that suppression of PP2A
B56 by antisense RNA led to an increase in cell proliferation,only the PP2A B562 and B563 isoforms, we were not able
to determine whether the B561 isoform was also suppressed. particularly when cells were cultured under conditions where
the concentration of specific essential amino acids was limitingHowever, since the B561, B562, and B563 splicing variants
share exons 1–12, we speculate that introduction of the PP2A (Figure 2C). When compared to cells expressing a control vector,
B563 antisense RNA also targets and suppresses the B561 cells expressing the antisense PP2A B563 RNA grew similarly
isoform. to cells expressing ST and exhibited the ability to continue to
Since each of the other members of the PP2A B56 family proliferate in low levels of glutamine (0.375 mM) or leucine (80
including B56, B56, B56 and B56 shares approximately M) (Figure 2C). Consistent with these observations, we noted
68% amino acid identity with B56 subunit (McCright and that the phosphatase activity of PP2A immune complexes was
Virshup, 1995), it remained possible that this PP2A B563 anti- inhibited 43% in cells expressing ST and 45% in cells expressing
sense RNA also perturbed other PP2A B56 subunits. Using the PP2A B563 antisense RNA (Figure 2D).
antibodies specific for the PP2A B56, , and  isoforms, we To assess the impact of PP2A B56 subunit suppression in
found that the expression of the antisense PP2A B563 RNA cell transformation and tumorigenicity, we then tested whether
failed to alter the expression of PP2A B56, B56, or B56 these cells were able to grow in an anchorage-independent
(Figure 2B). These observations indicate that expression of an manner or as subcutaneous tumors in immunodeficient mice.
antisense RNA complementary to the PP2A B563 subunit spe- As shown in Figure 2E, HEK TERAS563 cells formed colonies
cifically suppresses members of the PP2A B56 family in human in soft agar and tumors in immunodeficient mice in a manner
cells. similar to HEK TERST cells. In contrast, expression of the PP2A
B55 antisense RNA showed no effects on PP2A phosphatase
activity, cell proliferation, and cell transformation (Figure 2).Functional effects of suppressing PP2A B56 expression
We then examined the effects of suppressing PP2A B56 ex- In order to further address the specificity of these antisense
constructs in suppressing PP2A B55 and B56 protein levels,pression on PP2A activity, cell proliferation, and cell transforma-
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Figure 3. Suppression of PP2A B subunit expression by shRNA
A: Expression of PP2A B55-specific and B56-specific shRNA (SHRNA) in 293T
cells expressing the indicated PP2A subunit (PP2A). For each sample, 100
g of whole cell lysate was separated by SDS-PAGE and immunoblotted
with antibodies specific for the indicated proteins.
B: Anchorage-independent growth of HEK TER cells expressing a control
vector (Vector), B56-specific shRNA (SHB56), or PP2A B55-specific shRNA Figure 4. Overexpression of PP2A B563 attenuates ST-induced tumorige-
(SHB55). The mean  SD for 3 experiments is shown. HEK TERST cells formed nicity
larger colonies than HEK TERSHB56 cells. A: Immunoblotting for PP2A A, B562, and B563 (showed as B56), FLAG,
B55, C, ST, and -actin in HEK TERVB, TERSTB, TERB563, TERB563-ST,
TERB55, and TERB55-ST cells. V and B refer to control vectors. For these
experiments, FLAG-epitope-tagged versions of PP2A B56 and B55 were
used.we generated vectors that drive the expression of small hairpin
B: Cell proliferation for HEK TERVB (), TERSTB (), TERB563 (, upper panel)
RNAs (shRNA) specific for these genes (Masutomi et al., 2003; and TERB55 (, lower panel), TERB563-ST (, upper panel) and TERB55-ST
Stewart et al., 2003). We confirmed that these shRNAs sup- (, lower panel). The data are shown as the mean  SD for 3 experiments.
C: Anchorage-independent growth and tumorigenicity of the cell lines indi-pressed the expression of particular PP2A B subunits by intro-
cated in A. The data are shown as the mean  SD for 3 experiments. Tumorsducing these PP2A B55- and B56-specific shRNAs together
are reported as number of tumors formed/number of injection sites.with either a control vector or an expression vector encoding
the corresponding PP2A subunit into 293T cells (Figure 3A).
These shRNA vectors were then used to infect HEK TER cells
in order to assess cell transformation. HEK TER cells infected duce any change in these parameters (Figures 4B and 4C).
with the B55-specific shRNA (HEK TERSH55) formed few Taken together, these observations suggest that interactions
colonies in soft agar, indistinguishable from those formed by among ST, PP2A B563, and the PP2A A-C subunits regulate
HEK TER cells infected with a control shRNA vector. In contrast, tumorigenic potential in these cells.
HEK TER cells infected with a vector carrying a PP2A B56- In consonance with these functional experiments, we found
specific shRNA (HEK TERSH56) formed many more colonies, that expression of ST in HEK 293T cells using adenoviral vectors
albeit fewer than formed by HEK TERST (Figure 3B). These displaces PP2A B56, B561, or B563 PP2A AC complexes
observations suggest that expression of ST and loss of B56 to a similar degree (Figure 5A). Specifically, expression of ST
subunit expression have similar biochemical effects on PP2A reduced the amount of C subunit found associated with PP2A
and induce similar functional consequences. B56, B561, and B563 to 56  11%, 55  17%, and 70 
17% of the levels observed in the absence of ST expression,
Introduction of the PP2A B563 subunit attenuates respectively. In addition, the expression of ST induced a small
transformation potential decrease in the expression level of each PP2A B56 subunit,
Since we postulated that ST displaces the PP2A B56 subunit, perhaps due to degradation of some displaced B56 subunits.
we attempted to verify the functional interaction of ST and PP2A Similarly, we found that the amount of ST associated with the
complexes containing B56 by overexpressing B563 in HEK PP2A AC complex was diminished in whole cell lysates derived
TERST cells. After introduction of a retroviral vector encoding from HEK TER cells coexpressing PP2A B563 and ST (HEK
a FLAG-epitope-tagged version of PP2A B563, we noted an TERB563-ST cells) (Figure 5B). Moreover, when we isolated
increase in the expression level of PP2A B563 (Figure 4A). immune complexes with an antibody specific for the PP2A A
Functionally, the coexpression of PP2A B563 in TERST cells subunit, we noted that overexpression of PP2A B563 or PP2A
(named TERB563-ST cells) reduced cell proliferation (Figure B55 decreased the amount of ST associated with the PP2A
4B), anchorage-independent growth, and tumorigenicity in im- A subunit. Similar results were obtained when we mixed purified
munodeficient animal hosts (Figure 4C), while coexpression of proteins in vitro (data not shown). Specifically, in cells express-
ing both ST and PP2A B55 (HEK TERB55-ST), we noted aPP2A B55 in TERST cells (named TERB55-ST) failed to in-
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Figure 5. Expression of ST displaces PP2A B sub-
units
A: Introduction of ST using adenoviral vectors dis-
places members of the PP2A B56 family from the
PP2A A and C subunits. Human 293 cells were
transfected with specific HA-epitope-tagged
PP2A B56 subunits and then infected 24 hr later
with either adenovirus expressing ST (ST) or con-
trol adenovirus containing only the CMV pro-
moter (CMV). Immune complexes containing
HA-tagged-B56 were isolated and immunoblot-
ted in parallel with whole cell lysates for the pres-
ence of HA-tagged-B56 isoforms, associated C
subunit, and ST. Expression of ST in human 293
cells reduced the amount of C subunit coimmu-
noprecipitated with each of the HA-tagged
PP2A B56 isoforms tested. Quantitation of 4 sepa-
rate experiments showed that the introduction
of ST decreased the amount of PP2A C subunit
found associated with PP2A B56, B561, and
B563 to 56  11%, 55  17%, and 70  17%
(mean  SD) of control levels, respectively. The
C subunits migrate sometimes as singlets and
sometimes as doublets. This pattern of migration
in SDS-PAGE has been noted previously for en-
dogenous and epitope-tagged PP2A C subunits
(Campbell et al., 1995; Turowski et al., 1995) and
does not appear to be due to degradation.
B: Interactions among ST, PP2A A, C, and B
subunits. The indicated cells were lysed, and im-
munoprecipitation was performed with the ST-
specific mAb Pab 430 (top) or the PP2A A sub-
unit-specific mAb 6F9 (bottom). Immunoblotting
was subsequently performed with antibodies
specific for PP2A A, C, B55, B56, and ST.
Coexpression of PP2A B563 and ST displaced 38% of ST and 63% of B56 from PP2A A, while coexpression of B55 and ST displaced 66% of ST and nearly
all of the PP2A B55 from PP2A A as determined by densitometry using the amount of PP2A A in the immune complex to normalize expression levels. A
representative experiment of 3 independent experiments is shown.
nearly complete loss of B55 subunit binding to PP2A A and PP2A A, C, B56, and B55 proteins. Although we did not
detect significant alterations in the level of mRNA for each ofa 66% decrease in the amount of ST bound to PP2A A. Similarly,
in cells expressing both ST and PP2A B563, we noted a 63% these PP2A subunits in these lung cancer cell lines using real
time RT-PCR as compared to immortalized human airway epi-decrease in the amount of PP2A B563 bound to PP2A A and
a 38% decrease in the amount of ST bound to PP2A A. Taken thelial cells (Lundberg et al., 2002) (data not shown), we failed
to detect the PP2A B56 proteins in all lung cancer cells (Figuretogether, these findings suggest that coexpression of PP2A
B563 with ST attenuates the tumorigenic potential induced by 6A). In contrast, PP2A B563 was readily detectable in HEK
TER cells.ST at least in part by competing with ST for A subunit binding.
Moreover, these observations are consistent with the view that To determine whether introduction of the PP2A B56 sub-
unit affected the tumorigenic phenotype of these lung canceralthough ST competes with several PP2A B subunits for binding
to the PP2A AC heterodimer, only a subset of these complexes cell lines, we introduced the PP2A B563 subunit into three
lung cancer cell lines (H1395, H1437, H446) by retroviral-medi-participate in human cell transformation.
PP2A A subunit mutations are found in a subset of human ated gene transfer (Figure 6B). Expression of PP2A B563 sup-
pressed cell proliferation (Figure 6C) and reduced the numbercancers. Specifically, PP2A A subunit mutations were found
in 15% of primary lung tumors, 6% of lung tumor derived cell of colonies that formed in soft agar (Figure 6D). In contrast, the
introduction of the PP2A B55 subunit in parallel cultures failedlines, and 15% of primary colon tumors (Wang et al., 1998),
and alterations in both PP2A A and A subunit isoforms have to alter the proliferation rate or the ability of these cell lines to
grow in an anchorage-independent manner (Figures 6C andbeen reported in a variety of primary human cancers (Calin et
al., 2000). Expression of these PP2A mutants in vitro demon- 6D). Moreover, introduction of PP2A B563 into BJ fibroblast
cell lines immortalized with hTERT that express endogenousstrated that each of these PP2A A subunit mutants is defective
in binding either the PP2A B or the PP2A B and C subunits PP2A B563 failed to alter the proliferative potential of these
cells (Figure 6E). Expression of PP2A B563 in the breast cancer(Ruediger et al., 2001a, 2001b). These observations suggest
that regulation of PP2A activity by loss or mutation of particular cell line MCF-7 and the prostate cancer cell line DU-145 also
suppressed cell proliferation and inhibited growth in soft agarA and B subunits may play an important role in tumorigenesis.
To address whether alterations of PP2A B subunit expression (data not shown). These observations suggest that the level of
B563 expression plays a critical role in the transformed behav-also occur in spontaneously arising human tumors, we selected
10 lung cancer cell lines and measured the expression of the ior of these human cancer cell lines.
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Figure 6. Introduction of PP2A B563 into lung
cancer cells inhibits cell proliferation and an-
chorage-independent growth
A: Immunoblotting of the PP2A subunits, A,
B55, B56, and C in lung cancer cell lines and
HEK TERV cells.
B: The H1395, H446, and H1437 lung cancer cell
lines were infected by a control retrovirus
(Vector), a retrovirus encoding FLAG-epitope
tagged-PP2A B563 (B563), or a retrovirus en-
coding FLAG-epitope tagged-PP2A B55 (B55)
to generate the cell lines indicated. Immunoblot-
ting with antibodies specific for PP2A A, C,
B55, B563, FLAG, and -actin is shown.
C: Cell proliferation of lung cancer cell lines ex-
pressing a control vector (), PP2A B563 (),
and PP2A B55 ().
D: Anchorage-independent growth of lung can-
cer cell lines expressing a control vector (black
bars), PP2A B563 (gray bars), or PP2A B55
(white bars). The data are expressed as the
mean  SD for 3 experiments.
E: Proliferation of immortalized BJ fibroblasts ex-
pressing a control vector (), and PP2A B563
(). Immunoblotting with antibodies specific for
FLAG and -actin are also shown (inset).
Discussion expression correlates with several surrogate measures of cell
transformation, the mechanism by which these alterations in
Several groups have demonstrated that the interaction of SV40 PP2A function lead to cell transformation remain undefined. For
ST with PP2A contributes to the transformation of human cells example, loss of PP2A B56 expression may alter the phosphor-
(Mumby, 1995; Yu et al., 2001; Hahn et al., 2002). ST forms ylation of specific PP2A substrates or the subcellular localization
stable complexes with PP2A (Pallas et al., 1990), and this inter- of the PP2A holoenzyme. Alternatively, since PP2A B56 binds
action leads to partial enzymatic inhibition of PP2A (Yang et al., both APC and cyclin G, suppression of this PP2A B subunit
1991). The binding of ST with the PP2A A and C subunits has may directly perturb specific signaling pathways. Although fur-
been shown to displace the PP2A B55 subunit (Pallas et al., ther work is required to understand how alterations in PP2A
1990; Sontag et al., 1993). Here we confirm that ST competes B56 function contribute to cancer development in spontane-
with the PP2A B55 subunit for binding to PP2A A and C sub- ously arising human tumors, these observations identify specific
units; however, this interaction fails to reverse ST-dependent PP2A complexes that merit further investigation.
cell transformation. In contrast, ectopic expression of PP2A The functional effects of expressing ST or suppressing the
B563 disrupts ST-PP2A AC complexes and partially reverses expression of PP2A B56 involve inhibition of PP2A enzymatic
ST-dependent anchorage-independent growth and tumor for- function. OA treatment of immortalized, nontumorigenic cells
expressing LT, hTERT, and H-RAS but lacking ST stimulatesmation. Furthermore, suppression of PP2A B56 subunit ex-
pression functionally mimics the introduction of SV40 ST in this cell proliferation and permits anchorage-independent growth.
Although OA not only inhibits PP2A, but also PP1, PP2B, PP4,model of human cell transformation.
Taken together, these observations suggest that the effects and PP5 (Millward et al., 1999), the concentration of OA required
for inhibiting PP1, PP2B, and PP2C is higher than 1M (Millwardof ST in human cell transformation derive, at least in part, from
interactions of ST with PP2A complexes containing the B56 et al., 1999), well above the concentrations used herein. Since
OA is a known potent tumor promoter (Suganuma et al., 1988;subunit. While the relationship between ST and PP2A B563
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Fujiki, 1992), these observations suggest that some of its tumor subunits, and using specific shRNA, we have successfully sup-
pressed PP2A B56 protein expression in HEK TER cells andpromotion activities depend upon the inhibition of PP2A.
Many potential PP2A substrates have been reported, includ- observed anchorage-independent growth in such cells. Never-
theless, it remains possible that more than one PP2A B56 familying several classes of protein kinases, transcription factors, and
cell cycle regulators. Indeed, PP2A modulates the activity of member may contribute to human cell transformation.
Indeed, prior studies of PP2A B56 mRNA expression inmore than 30 protein kinases in vitro, and PP2A forms stable
complexes with several kinases including p70 S6, CaM kinase human melanoma have led to conflicting observations (Francia
et al., 1999; Deichmann et al., 2001). One group reported down-IV, RAF-1, and p21-activated kinase (PAK1) (Millward et al.,
1999). The existence of multiple families and isoforms of PP2A regulation of PP2A B56 mRNA in tissue samples derived from
human primary melanoma and melanocytic nevi using sub-regulatory subunits is consistent with the hypothesis that differ-
ent PP2A complexes perform specific and distinct physiological tractive suppression hybridization (Deichmann et al., 2001). In
contrast, another group found that PP2A B56 mRNA is ex-functions and that particular B subunits may confer substrate
specificity upon the PP2A AC core enzyme (Sola et al., 1991; pressed in both human melanoma cell lines and normal epider-
mal melanocytes using in situ hybridization (Francia et al., 1999).Ferrigno et al., 1993; Cegielska et al., 1994). Moreover, the
interaction of PP2A with specific kinases may result in activation In addition, in B16 mouse melanoma cells, a truncated isoform
of PP2A B561 is expressed in a clone that exhibits increasedor inactivation of the kinase, depending upon the particular
substrate (Gomez and Cohen, 1991; Mueller et al., 1995; Cegiel- invasiveness (BL6 cells), implying that mutations in B561 pro-
mote cell invasiveness and neoplastic progression (Ito et al.,ska et al., 1998; Ricciarelli and Azzi, 1998). Recent work impli-
cates the pathway regulated by phosphatidylinositol-3-kinase 2000). Consistent with these observations, we failed to detect
PP2A B56 protein in 10 lung cancer cell lines. Since cancer-(PI3K) as an important target of ST (Yuan et al., 2002; Zhao
et al., 2003). Specifically, expression of ST in human foreskin associated mutations of the PP2A A subunit appear to interfere
with the binding of particular PP2A B-type subunits (Ruedigerkeratinocytes, fibroblasts, and mammary epithelial cells leads
to increased and sustained AKT activation, which is necessary et al., 2001a, 2001b), it is also possible that such mutations act
to disrupt the binding of PP2A B56 to the PP2A A subunit.for human cell transformation. However, since activation of AKT
alone fails to suffice to achieve cell transformation (Zhao et al., Taken together, these observations suggest that perturbation
of the interaction of PP2A B56 with the A subunit is the critical2003), these observations indicate that several PP2A targets
participate in cell transformation. event in human cell transformation.
Although further study is required to determine whether spe-In addition, specific PP2A B subunits direct particular PP2A
complexes to distinct intracellular locations (Strack et al., 1998; cific PP2A B56 subunit mutations occur in many human tu-
mors, these observations implicate the intracellular pathwaysDagda et al., 2003). For example, PP2A complexes containing
PP2A B56, B56, and B56 localize to the cytoplasm, whereas regulated by PP2A holoenzymes containing B56 as important
participants in cellular transformation. Further elucidation ofPP2A complexes composed of PP2A B56 or B56 are concen-
trated in the nucleus (Sontag et al., 1995; McCright et al., 1996). these pathways will identify mutants that act as analogs of ST
and will facilitate the generation of models that will increasinglyMoreover, PP2A enzymes containing PP2A B55 are found
associated with microtubules (Sontag et al., 1995). Thus, ST mimic the phenotypes of naturally arising human tumor cells
and that will serve as useful platforms for drug discovery.may also influence PP2A function by targeting PP2A complexes
restricted to particular subcellular compartments or by altering
Experimental proceduresthe localization of specific PP2A complexes.
Although alterations in PP2A phosphatase activity may in-
Retroviral infection and cell lines
fluence cell transformation, PP2A B56 may also contribute to Amphotropic retroviruses were produced by transfection of the HEK 293T
tumor development through direct interactions with the tumor producer cell line with a specific retroviral vector and a vector encoding a
suppressor APC and/or cyclin G. By binding APC, PP2A B56 replication-defective helper virus, pCL-Ampho (Imgenex, San Diego, CA),
using Fugene 6 (Roche Molecular Biochemicals, Indianapolis, IN). HEK TERinhibits APC-axin complex formation, leading to destabilization
cells were generated from human embryonic kidney (HEK) cells as describedof the -catenin protein (Polakis, 2000). Moreover, expression
(Hahn et al., 2002). To generate the PP2A B563 and B55 antisense con-of PP2A B56 subunits including , , 3, , and  isoforms in
structs, wild-type B563 and B55 in the pCMV vector were used as the
HEK 293 cells alters the expression of -catenin (Seeling et al., templates for PCR to obtain full-length of B563 and B55 fragments amena-
1999). In addition, PP2A B56 also binds cyclin G (Okamoto et ble for cloning into the retroviral vector pMIG in the anti-sense (AS) orienta-
al., 1996; Bennin et al., 2002; Okamoto et al., 2002), a p53 tion. pMIG-ASB563, pMIG-ASB55, pMIG-FLAG-B563, pMIG-FLAG-
B55, and corresponding control retroviral vectors were introduced intotarget gene (Okamoto and Beach, 1994; Okamoto et al., 1996),
HEK TER cells and selected for green fluorescent protein (GFP)-expressingsuggesting that the PP2A and p53 pathways are interconnected
cells using a fluorescent-activated cell sorter (FACS). After 2 rounds ofby cyclin G. Further work is necessary to determine the func-
infection, 70% to 90% of the cells expressed GFP, and 50% of these GFP-tional consequences of these interactions in malignant transfor-
expressing cells were retained by FACS. To make retroviruses expressing
mation. shRNAs, oligonucleotides were inserted in the vector pMKO.1-puro (Masu-
Since B56 family members share 68% identity in amino acid tomi et al., 2003; Stewart et al., 2003) modified by replacing the puromycin
resistance gene with hrGFP (pMKO.1-GFP). The shRNAs were generatedsequence (McCright and Virshup, 1995), it remains possible that
by cloning nucleotides 1156–1175 of PP2A B55 and nucleotides 423–442each member of the PP2A B56 family contributes to the control
of PP2A B56, followed by a 6 bp loop and the corresponding antisenseof cell growth and cancer development. Moreover, the PP2A
sequence followed by five thymidines into pMKO.1-GFP. To generate HEKB563 antisense RNA used in these studies may also target
TERB563-ST and TERB55-ST cell lines, pWZL-blast-ST was introduced
other PP2A B56 subunits. However, using antibodies specific into TERB563 and TERB55 cells. The TERVB and TERSTB cell lines were
for PP2A B56, B56 and B56, we have eliminated the possibil- generated by introducing the pWZL-blasticidin retroviral vector into TERV
and TERST cells. These cell lines were selected with blasticidin (2 g/ml).ity that this PP2A B563 antisense RNA targets these three
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The human lung cancer cell lines H1395, H1437, and H446 were infected with Anchorage-independent growth and tumor formation
pMIG-FLAG-B563 or pMIG-FLAG-B55, respectively, and subsequently Growth of cells in soft agar and in immunodeficient animals was performed
selected by FACS. Immortalized human fibroblasts (BJ) expressing hTERT as previously described (Hahn et al., 1999). Anchorage-independent colonies
were propagated as described (Hahn et al., 2002). were counted with the MultiImage imaging counter (Alpha Innotech Corp,
San Leandro, CA).
Immunoblotting and immunoprecipitation
Cells were suspended in lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM Proliferation assays
NaCl, 1 mM EDTA, 1 mM EGTA, protease inhibitor cocktail [Roche] and HEK cells were maintained in minimal Eagle medium  (MEM) supple-
0.5% Nonidet P-40) and cleared of insoluble material by centrifugation. The mented with 10% IFS. To generate proliferation curves, cells were plated
supernatants (100 g) were subjected to SDS-PAGE in 7.5%–15% gradient in triplicate and counted in a Z2 Particle Count and Size Analyzer (Beckman-
acrylamide gels and immunoblotting performed. The antibodies used in- Coulter, Miami, FL). To test the growth of cells at a limiting glutamine or
cluded anti-PP2A A 6F9 (Covance, Richmond, CA), anti-PP2A C (Upstate, leucine concentration, glutamine-free or leucine-free medium was supple-
Lake Placid, NY), anti-PP2A B56, anti-B56 (Santa Cruz, CA), and Flag mented with dialyzed IFS and 0.375 mM glutamine or 80 M leucine repre-
M2 (Sigma-Aldrich Co., St. Louis, MO). Affinity-purified polyclonal antibodies senting 10% of the usual glutamine or leucine concentration. To measure
were raised against a PP2A B55 peptide (CFSQVKGAVDDDV) correspond- IC50 of OA in these cells, 104 TERV cells were treated with either 2.0 nM,
ing to the N-terminal amino acids 13–25, a PP2A B56 peptide 4.0 nM, 8.0 nM, or 16.0 nM OA, and cell number was counted at 24 hr.
(CPQAQKDPKKDR) corresponding to amino acids 471–480 of B563 and Using this approach the IC50 for toxicity of OA to these cells was determined
residues 431–441 of B562, a PP2A B56 peptide (QSQPPSSNKRPSNS) to be 6 nM.
corresponding to amino acids 49–62, and a SV40 ST peptide (CDIIGQT
TYRDLKL) corresponding to the C-terminal amino acids 161–174 (Zymed Acknowledgments
Laboratories, South San Francisco, CA). For immunoprecipitation, each anti-
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